Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
834,731,296
-
Number of holders
-
130
-
Total 13F shares, excl. options
-
20,321,786
-
Shares change
-
-1,456,294
-
Total reported value, excl. options
-
$654,386,435
-
Value change
-
-$49,621,742
-
Put/Call ratio
-
2.31%
-
Number of buys
-
72
-
Number of sells
-
-44
-
Price
-
$32.2
Significant Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q2 2018
147 filings reported holding RDY - DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share as of Q2 2018.
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) has 130 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20,321,786 shares
of 834,731,296 outstanding shares and own 2.43% of the company stock.
Largest 10 shareholders include ROYAL BANK OF CANADA (4,160,922 shares), Commonwealth Bank of Australia (1,760,194 shares), BlackRock Inc. (1,559,768 shares), VANGUARD GROUP INC (1,229,265 shares), DIMENSIONAL FUND ADVISORS LP (835,827 shares), STATE STREET CORP (762,061 shares), Mondrian Investment Partners LTD (759,419 shares), RENAISSANCE TECHNOLOGIES LLC (573,810 shares), AQR CAPITAL MANAGEMENT LLC (533,007 shares), and D. E. Shaw & Co., Inc. (525,323 shares).
This table shows the top 130 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.